Kolodner et al. Remain Optimistic for Health 2.0


By Neil Versel, contributing editor

October 28, 2008 | SAN FRANCISCO—In a session about online clinician social networks, moderator Enoch Choi remarked that more than half the companies that presented on a similar panel a year ago were no longer in business. And yet the Palo Alto, Calif., urgent care physician and medical project manager at online health community MedHelp.org, remained optimistic that user-generated health care has a bright future.

After all, medical imaging sharing site MyPACS.net, a panelist in Choi’s session at the third semi-annual health 2.0 conference, was purchased by 175-year-old McKesson Corp. earlier this year. A year ago almost to the day, restaurant rating service Zagat Survey began a foray into physician rating, while consumer rating site Angie’s List made a similar move in March.

Perhaps these developments are symbolic of health 2.0 as a whole. There is a lot of promise for user-generated online content to revolutionize health care, yet plenty of doubt about how to make money providing such platforms. And even old-line companies want to participate.

The fact that the top health-IT advocate in the federal government not only made the coast-to-coast trip from Washington to speak at the conference, but stayed for two full days to talk personally with many of the more than 1,000 attendees, added more legitimacy to the sector.

“It’s important to understand that we’re early in the hype cycle,” national health-IT coordinator Robert Kolodner, said Wednesday at the conference. He urged patience for anyone investing in the sector, particularly in these skittish economic times.

“Keep the faith,” Kolodner said. “The fact that [business success] doesn’t happen in the next six months doesn’t mean that it’s not going to happen.”

Kolodner himself had led the development of an interactive portal, the My HealtheVet online personal health record (PHR) and wellness site, when he was chief of medical informatics at the Veterans Health Administration.

Indeed, PHRs are a big part of the health 2.0 universe, significant enough to convince both Microsoft and Google to launch PHR and data-aggregation platforms in the past 13 months. Executives from Microsoft HealthVault and Google Health joined leaders of WebMDYahoo! Health, and insurance giant Aetna, owner of PHR firm Active Health Management, in a plenary session on that very topic.

Kolodner, offering commentary at the end of the session, said consumer aggregators were “necessary but not sufficient” to engaging patients and building the nascent National Health Information Network. Google Health product manager Roni Zeiger, used exactly the same words to describe his product, and PHRs in general.

MyPACS.net creator Rex Jakobovits said success in health 2.0 is all about building critical mass. “One that’s there, it’s self-perpetuating,” he said.

Click here to log in.

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.